
Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease : 3-Year Outcomes From a Randomized Clinical Trial
Keywords: پلیمر; biodegradable; drug-eluting stent; everolimus; polymer; randomized trial; restenosis; sirolimusCI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; SES, sirolimus-eluting stent